Franklin Genomic Advancements ETF (HELX)

• Market cap: $16.6M
• 1 day: -1.72%
• 5 days: -0.59%
• 1 month: 5.69%
• 3 months: 9.84%
• 6 months: 7.61%
• Year to date: 4.27%
• 1 year: -7.21%
• 5 years: -11.52%
• 10 years: 26.29%

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

12% more capital invested

Capital invested by funds: $2.21M [Q1] → $2.48M (+$275K) [Q2]

1.95% more ownership

Funds ownership: 20.42% [Q1] → 22.38% (+1.95%) [Q2]

13% less funds holding

Funds holding: 8 [Q1] → 7 (-1) [Q2]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2